Want to see HIND full AI Analyst Report?
HIND Stock Chart & Stats
$2.06
$0.00(0.00%)
At close: 4:00 PM EDT
$2.06
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1.75 - $18.60
Previous CloseN/A
Volume1.31K
Average Volume (3M)16.09K
Market Cap
$13.97M
Enterprise Value$3.50M
Total Cash (Recent Filing)$8.80M
Total Debt (Recent Filing)$22.55K
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Nov 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-38.80
Shares Outstanding7,018,528
10 Day Avg. Volume12,409
30 Day Avg. Volume16,085
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.04
Price to Sales (P/S)23.26
P/FCF Ratio-1.98
Enterprise Value/Market Cap0.25
Enterprise Value/Revenue2.60
Enterprise Value/Gross Profit5.41
Enterprise Value/Ebitda-0.26
Forecast
1Y Price Target
$11.50Price Target Upside458.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.69
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Capital-structure TighteningReducing authorized shares materially tightens the company’s capital structure, lowering future dilution risk and improving per-share upside for existing holders. Over a multi-month horizon it strengthens governance signaling and makes any future equity raises more deliberate and potentially less frequent.
Low Leverage / Positive EquityVery low debt levels and recent positive equity provide financial flexibility and limit interest burden, enabling the company to pursue restructurings or strategic pivots without heavy fixed financing costs. This balance-sheet capacity matters over months when looking to fund operations or transactions.
Healthy Gross MarginA near-50% gross margin indicates the core product economics can support profitability if operating expenses are addressed. Structurally this suggests the business has intrinsic unit-level profitability that could scale into positive operating margins with disciplined cost control or higher volumes.
Bears Say
Sharp Revenue DeclineA steep, recent drop in revenue erodes scale needed to absorb fixed costs and undermines commercial traction. Over a 2–6 month horizon, continued top-line decline limits ability to stabilize margins, weakens negotiating leverage with partners, and increases reliance on external capital to sustain operations.
Persistent Cash BurnSignificant negative operating and free cash flow indicate the business does not self-fund operations and will need financing to continue. Ongoing burn constrains strategic options, raises dilution or refinancing risk, and limits ability to invest in growth or execute restructuring without external capital.
Multi-year Unprofitable OperationsSustained, large losses across multiple years show the company has not yet converted product economics into net profits. This persistent unprofitability weakens returns on equity and implies that absent durable revenue growth or significant cost cuts, long-term value creation is uncertain and dependent on execution or financing.
Vyome Holdings News
HIND FAQ
What was Vyome Holdings’s price range in the past 12 months?
Vyome Holdings lowest stock price was $1.75 and its highest was $18.60 in the past 12 months.
What is Vyome Holdings’s market cap?
Vyome Holdings’s market cap is $13.97M.
When is Vyome Holdings’s upcoming earnings report date?
Vyome Holdings’s upcoming earnings report date is Nov 24, 2026 which is in 116 days.
How were Vyome Holdings’s earnings last quarter?
Vyome Holdings released its earnings results on May 28, 2026. The company reported -$0.15 earnings per share for the quarter, the consensus estimate of -$0.15 by $0.
Is Vyome Holdings overvalued?
According to Wall Street analysts Vyome Holdings’s price is currently Undervalued.
Does Vyome Holdings pay dividends?
Vyome Holdings does not currently pay dividends.
What is Vyome Holdings’s EPS estimate?
Vyome Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vyome Holdings have?
Vyome Holdings has 7,018,528 shares outstanding.
What happened to Vyome Holdings’s price movement after its last earnings report?
Vyome Holdings reported an EPS of -$0.15 in its last earnings report, expectations of -$0.15. Following the earnings report the stock price went up 4.911%.
Which hedge fund is a major shareholder of Vyome Holdings?
Currently, no hedge funds are holding shares in HIND
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vyome Holdings
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
HIND Stock 12 Month Forecast
Average Price Target
$11.50
▲(458.25% Upside)
Technical Analysis
Ownership Overview
6.49% Insiders
0.36% Mutual Funds
― Other Institutional Investors
93.01% Public Companies and
Individual Investors